Epigenetic modification and BRAF gene mutation in thyroid carcinoma

Thyroid cancer remains the most prevailing endocrine malignancy, and a progressively increasing incidence rate has been observed in recent years, with 95% of thyroid cancer represented by differentiated thyroid carcinomas. The genetics and epigenetics of thyroid cancer are gradually increasing, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Guo, Chen, Juan, Zhou, Jun, Xiao, Shuai, Zeng, Weihong, Xia, Jiliang, Zeng, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684614/
https://www.ncbi.nlm.nih.gov/pubmed/34923978
http://dx.doi.org/10.1186/s12935-021-02405-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684614/
https://www.ncbi.nlm.nih.gov/pubmed/34923978
http://dx.doi.org/10.1186/s12935-021-02405-w

Ejemplares similares